SLT Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
965
+438
+83% +$448K 0.72% 37
2026
Q1
$485K Buy
527
+106
+25% +$107K 0.33% 70
2025
Q4
$452K Buy
421
+146
+53% +$140K 0.29% 82
2025
Q3
$210K Sell
275
-1
-0.4% -$744 0.14% 119
2025
Q2
$215K Hold
276
0.16% 93
2025
Q1
$228K Buy
+276
New +$230K 0.21% 68

Other funds holding LLY

SLT Holdings's LLY Position: Q2 2026 in Review

SLT Holdings increased its Eli Lilly (LLY) stake by 83% in Q2 2026, buying an estimated $448K and bringing the position to 965 shares worth $1.16M. The position accounts for 0.72% of the portfolio, ranked #37.

SLT Holdings first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 1,587 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • SLT Holdings held 965 shares of Eli Lilly worth $1.16M as of Q2 2026.
  • SLT Holdings bought 438 Eli Lilly shares in Q2 2026, an estimated $448K.
  • Eli Lilly made up 0.72% of SLT Holdings's portfolio in Q2 2026, its #37 holding.
  • SLT Holdings first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 1,587 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on SLT Holdings's 13F filing for Q2 2026, filed 17 Jul 2026.